This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name : 
Abnova
product type : 
antibody
product name : 
CTNNB1 (phospho Y142) polyclonal antibody
catalog : 
PAB7914
quantity : 
100 uL
clonality : 
polyclonal
host : 
domestic rabbit
conjugate : 
nonconjugated
reactivity : 
human, mouse, rat
application : 
western blot, ELISA
product information
catalog id : 
PAB7914
product name : 
CTNNB1 (phospho Y142) polyclonal antibody
product description : 
Rabbit polyclonal antibody raised against synthetic phosphopeptide of CTNNB1.
gene name : 
CTNNB1
gene alias : 
CTNNB DKFZp686D02253 FLJ25606 FLJ37923
gene description : 
catenin (cadherin-associated protein), beta 1, 88kDa
immunogen : 
Synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding Y142 of human CTNNB1.
form : 
Liquid
recommend dilutions : 
ELISA (1:2000). Western Blot (1:500). The optimal working dilution should be determined by the end user.
storage buffer : 
In PBS (50% glycerol, 1 mg/mL BSA, 0.05% sodium azide)
storage instruction : 
Store at -20 C.  Aliquot to avoid repeated freezing and thawing.
quality control testing : 
Antibody Reactive Against Synthetic Peptide.
note : 
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality : 
Antibody
raised in host species : 
Rabbit
antigen species target species : 
Human
specificity : 
This peptide sequence has one amino acid difference from a sequence around tyrosine 133 of human g-Catenin. These human sequences are highly conserved in rat and mouse beta- and g-Catenins.
species reactivity cross reactivity : 
Human,Mouse,Rat
application key : 
ELISA,WB-Ce
size : 
100 uL
autodate : 
2009-04-01
updatetime : 
2011-02-11 11:32:11
company information
Abnova
9th Fl., No.108, Jhouzih St. 
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments
